Motonari Ri

Motonari Ri

Auto-generated profile, based on publicly available information

Motonari Ri

Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2017 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
MRMotonari Ri
Motonari Ri
SASusumu Aikou
Susumu Aikou
YSYasuyuki Seto
Yasuyuki Seto
In recent years, both the actual number of overweight/obese individuals and their proportion of the population have steadily been rising worldwide and obesity‐related diseases have become major health concerns. In addition, as obesity is associated with an increased incidence of gastroenterological cancer, the number of obese patients has also been increasing in the field of gastroenterological surgery. While the influence of obesity on gastroenterological surgery has been widely studied, very few reports have focused on individual organs or surgical procedures, using a cross‐sectional study design. In the present review, we aimed to summarize the impacts of obesity on surgeries for the esophagus, stomach, colorectum, liver and pancreas. In general, obesity prolongs operative time. As to short‐term postoperative outcomes, obesity might be a risk for certain complications, depending on the procedure carried out. In contrast, it is possible that obesity doesn't adversely impact long‐term surgical outcomes. The influences of obesity on surgery are made even more complex by various categories of operative outcomes, surgical procedures, and differences in obesity among races. Therefore, it is important to appropriately evaluate perioperative risk factors, including obesity.

20 May 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
MRM. Ri
M. Ri
SNSouya Nunobe
Souya Nunobe
MHM. Honda
M. Honda
EAE. Akimoto
E. Akimoto
TKT. Kinoshita
T. Kinoshita
TAT. Abe
T. Abe
Background Omentectomy is performed widely for locally advanced gastric cancer to prevent disease recurrence. However, its clinical benefit is unknown. Methods This retrospective cohort study compared the outcome of gastrectomy with preservation of the omentum (GPO) and gastrectomy with resection of the omentum (GRO) among patients with cT3–T4 gastric cancer who underwent gastrectomy between 2006 and 2012 in one of five participating institutions. A consensus conference identified 28 variables potentially associated with outcome after gastrectomy for the estimation of propensity scores, and propensity score matching (PSM) was undertaken to control for possible confounders. Postoperative surgical outcomes, overall survival and disease recurrence were compared between GPO and GRO. Results A total of 1758 patients were identified, of whom 526 remained after PSM, 263 in each group. Median follow‐up was 4·9 (i.q.r. 3·1–5·9) years in the GRO group and 5·0 (2·5–6·8) years in the GPO group. The incidence of postoperative complications of Clavien–Dindo grade III or more was significantly higher in the GRO group (17·5 versus 10·3 per cent; P = 0·016). Five‐year overall survival rates were 77·1 per cent in the GRO group and 79·4 per cent in the GPO group (P = 0·749). There were no significant differences in recurrence rate or pattern of recurrence between the groups. Conclusion Overall survival and disease recurrence were comparable in patients with cT3–4 gastric cancer who underwent GPO or GRO.

16 July 2021 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
MRMotonari Ri
Motonari Ri
KKKoshi Kumagai
Koshi Kumagai
KNKen Namikawa
Ken Namikawa
SAShinichiro Atsumi
Shinichiro Atsumi
MHMasaru Hayami
Masaru Hayami
SNSouya Nunobe
Souya Nunobe
Aim: To treat upper third gastric cancer, proximal gastrectomy (PG), a function‐preserving procedure, is recommended for early lesions when at least half the distal stomach can be preserved, while total gastrectomy (TG) is standard for locally advanced lesions. Oncological feasibility, when applying PG for such lesions, remains unknown.Methods: We reviewed patients undergoing TG for clinical (c) T2–T4 upper third gastric cancer between 2006 and 2015. Preoperative tumor locations were further classified into the cardia, fornix, and gastric body based on endoscopic findings. The metastatic rate and therapeutic value index for lymph node (LN) dissection were determined, and characteristics of patients with distal LN (No. 4d, 5, and 6) metastasis (DLNM) were reviewed. In addition, patients with pathological tumor invasion to the middle third (M) region were investigated.Results: We studied 167 patients. There were 8 (4.8%) with DLNM and 41 (24.6%) with pathological tumor invasion to the M region. As to regional stations, therapeutic indices for LN dissection at stations No. 4d, 5, 6, and 12a were zero or extremely low. No DLNM was detected in cT2 lesions or cT3/T4 lesions located within the cardia and/or the fornix. In addition, none of the lesions located within the cardia and/or the fornix by preoperative endoscopy extended to the M region in the pathological specimen.Conclusions: For upper third gastric cancer, PG without No. 12a dissection might be acceptable for cT2–T4 lesions located within the cardia and/or the fornix when considering the risk of DLNM and cancer‐positivity in the distal stump.

1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
TITomoyuki Irino
Tomoyuki Irino
MOManabu Ohashi
Manabu Ohashi
MHMasaru Hayami
Masaru Hayami
RMRie Makuuchi
Rie Makuuchi
MRMotonari Ri
Motonari Ri
SNSouya Nunobe
Souya Nunobe
Irino T, et al. J Gastric Cancer. 2025 Jan;25:e12. https://doi.org/10.5230/jgc.2025.25.e12

13 October 2020 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
MRMotonari Ri
Motonari Ri
SNSouya Nunobe
Souya Nunobe
RMRie Makuuchi
Rie Makuuchi
SISatoshi Ida
Satoshi Ida
KKKoshi Kumagai
Koshi Kumagai
TSTakeshi Sano
Takeshi Sano

1 January 2021 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
MRMotonari Ri
Motonari Ri
SNSouya Nunobe
Souya Nunobe
SISatoshi Ida
Satoshi Ida
NINaoki Ishizuka
Naoki Ishizuka
SAShinichiro Atsumi
Shinichiro Atsumi
TSTakeshi Sano
Takeshi Sano
Ri M, et al. J Gastric Cancer. 2021 Nov;21:e31. https://doi.org/10.5230/jgc.2021.21.e31